Study begins on vaccine to fight Zika

zika virus medications The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, has begun a phase 1 clinical trial on an investigational vaccine that’s intended to protect against a range of mosquito-transmitted diseases, including Zika, malaria, West Nile fever and dengue fever, and to hinder the ability of mosquitoes to transmit infections.

The small study of 60 healthy adults ages 18 to 50 will examine the safety of an investigational vaccine, known as AGS-v, and its ability to trigger the body’s immune response to mosquito saliva instead of to a specific virus or parasite that’s carried by mosquitoes.

Researchers are expected to complete the clinical trial by summer 2018. In the meantime, follow recommendations by the Centers for Disease Control and Prevention (CDC) to avoid being bitten by mosquitoes.

  • Use EPA-registered insect repellent.
  • Wear clothing that covers your arms, legs and feet.
  • Treat your clothing and gear with permethrin or buy pre-treated items.
  • Stay in places that have air conditioning or that use window and door screens.
  • Sleep under a mosquito bed net if sleeping outdoors, or if air conditioned or screened rooms are not available.

Visit the CDC’s website for more tips to protect yourself and your loved ones from mosquito bites.